𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance

✍ Scribed by A. Vermeeren; P. E. Danjou; J. F. O'Hanlon

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
217 KB
Volume
13
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Residual effects of zaleplon and zolpide
Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening
✍ Ian Hindmarch; Alain Patat; Neil Stanley; Isabelle Paty; Una Rigney πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 127 KB

The objective was to assess residual effects of zaleplon and zolpidem after a middle of the night administration. This was a randomized, double-blind, placebo-controlled, crossover study, conducted in 40 healthy young male and female subjects. Subjects were awakened in the middle of the night and ad

Lack of effects between rupatadine 10 mg
Lack of effects between rupatadine 10 mg and placebo on actual driving performance of healthy volunteers
✍ Eric Vuurman; Eef Theunissen; Anita van Oers; Cees van Leeuwen; Jelle Jolles πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 125 KB

## Abstract ## Introduction Rupatadine fumarate is a potent, selective, histamine H~1~‐receptor antagonist and PAF inhibitor with demonstrated efficacy for the relief of allergic rhinitis. Rupatadine does not easily cross the blood–brain barrier and is believed to be non‐sedating at therapeutic do

Residual effects on actual car driving o
Residual effects on actual car driving of evening dosing of chlorpheniramine 8 and 12 mg when used with terfenadine 60 mg in the morning
✍ A. Vermeeren; J. G. Ramaekers; C. J. Van Leeuwen; J. F. O'Hanlon πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 163 KB

The study was conducted according to a 4-way, observer-and subject-blind, cross-over design. Its purpose was to compare the repeated dose eects on actual driving performance of the following: the combination of chlorpheniramine 8 and 12 mg, in sustained release formulations, administered at bedtime